P62942 (FKB1A_HUMAN) Homo sapiens (Human)
Peptidyl-prolyl cis-trans isomerase FKBP1A UniProtKBInterProSTRINGInteractive Modelling
108 aa; Sequence (Fasta) ;
30 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
95 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of the ACVR1 (ALK2) kinase in complex with FKBP12 and the inhibitor E6201 |
Heteromer Q04771; | 100 | 1×E26; 7×EDO; 2×SO4; | |||
| Crystal structure of the cytoplasmic domain of the bone morphogenetic protein receptor type-1B (BMP… |
Heteromer O00238; | 100 | 1×LDN; | |||
| Crystal structure of CEP250 bound to FKBP12 in the presence of FK506-like novel natural product |
Heteromer Q9BV73; | 100 | 2×60Z; 13×EDO; 7×PEG; 2×PE8; 3×PGE; 3×PG4; 1×MG; | |||
| Crystal structure of FKBP-FRB T2098L mutant in complex with rapamycin |
Heteromer P42345; | 100 | 1×RAP; 8×ZN; 4×CL; | |||
| Crystal structure of MBP fused split FKBP in complex with rapamycin |
Heteromer P0AEX9; | 100 | 1×RAP; | |||
| Crystal structure of MBP fused split FKBP-FRB T2098L mutant in complex with rapamycin |
Heteromer P0AEX9; P42345; | 100 | 1×GLC; 1×RAP; 1×GOL; | |||
| Co-crystal structure of FKBP12, compound 7 and the FRB fragment of mTOR |
Heteromer P42345; | 99.06 | 1×0AN; 4×CA; 1×ACT; | |||
| ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP |
Heteromer P42345; | 100 | 1×ARD; | |||
| THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN… |
Heteromer P42345; | 100 | 1×RAD; | |||
| THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-(C16)-ETHOXY RAPAMYCIN COMPLEX INTERACTI… |
Heteromer P42345; | 100 | 1×RAD; | |||
| Crystal structure of the kinase domain of type I activin receptor (ACVR1) in complex with FKBP12 an… |
Heteromer Q04771; | 100 | 1×TAK; 5×SO4; 3×PG4; | |||
| Crystal Structure of a human Calcineurin A - Calcineurin B fusion bound to FKBP12 and FK-520 |
Heteromer P48454; P63098; | 100 | 4×CA; 1×EDO; 1×KXX; | |||
| Crystal structure of the kinase domain of ACVR1 (ALK2) in complex with FKBP12 and MU1700 |
Heteromer Q04771; | 100 | 1×7IO; 1×F; | |||
| CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12 |
Heteromer P36897; | 100 | 1×SO4; | |||
| THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN… |
Heteromer P42345; | 100 | 1×RAP; | |||
| ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP |
Heteromer P42345; | 100 | 1×ARD; | |||
| FKBP12-FRB in Complex with Compound 11 |
Heteromer P42345; | 100 | 1×XYU; | |||
| FKBP12-FRB in Complex with Compound 12 |
Heteromer P42345; | 100 | 1×XZ3; | |||
| NMR structure of FKBP12-mTOR FRB domain-rapamycin complex structure determined based on PCS |
Heteromer P42345; | 100 | 2×TB; | |||
| Structure of RyR1 in a closed state (C4 conformer) |
Heteromer P11716; P62943; | 100 | 4×ZN; | |||
| Structure of RyR1 in a closed state (C1 conformer) |
Heteromer P11716; P62943; | 100 | 4×ZN; | |||
| RMC-5552 in complex with mTORC1 and FKBP12 |
Heteromer P42345; Q8N122; Q9BVC4; | 100 | 1×XZ9; 1×XYU; | |||
| A drug and ATP binding site in type 1 ryanodine receptor |
Heteromer P0DP23; P11716; P62943; | 100 | 20×CA; 8×ATP; 4×ZN; 4×CFF; 4×KVR; 8×L9R; | |||
| Structure of RyR1 in an open state |
Heteromer P11716; P62943; | 100 | 4×ZN; | |||
| Structure of the rabbit ryanodine receptor RyR1 in complex with FKBP12 at 3.8 Angstrom resolution |
Heteromer P11716; P62943; | 100 | 4×ZN; | |||
| Structure of RyR1 in a closed state (C3 conformer) |
Heteromer P11716; P62943; | 100 | 4×ZN; | |||
| Structure of RyR1 in the open state in the presence of pentoxifylline |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×PNX; | |||
| Structure of RyR1 in the primed state in the presence of uracil |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×URA; | |||
| Structure of RyR1 in the open state in the presence of dyphylline |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×A1BD2; | |||
| Structure of RyR1 in the primed state in the presence of dyphylline |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×A1BD2; | |||
| Structure of RyR1 in the primed state in the presence of allopurinol |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×A1BD4; | |||
| Structure of RyR1 in the primed state in the presence of oxypurinol |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×141; | |||
| Structure of RyR1 in the primed state in the presence of oxopyricid |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×A1BD5; | |||
| Structure of RyR1 in the primed state in the presence of caffeine (reprocessed/reanalyzed from EMPI… |
Heteromer P0DP23; P11716; P62943; | 100 | 20×CA; 8×ATP; 4×ZN; 4×CFF; 4×KVR; 8×L9R; | |||
| Structure of RyR1 in the primed state in the presence of IBMX |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×IBM; | |||
| Structure of RyR1 in the primed state in the presence of pentoxifylline |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×PNX; | |||
| Structure of RyR1 in the open state in the presence of oxopyricid |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×A1BD5; | |||
| Structure of RyR1 in the primed state in the presence of enprofylline |
Heteromer P11716; P62943; | 100 | 4×ATP; 4×CA; 4×ZN; 4×A1BD3; | |||
| Cryo-EM structure of calcineurin fused beta2 adrenergic receptor in norepinephrine bound inactive s… |
Heteromer P07550; P63098; P63328; | 100 | 1×E5E; 1×FK5; | |||
| cryo-EM structure of calcineurin-fused beta2 adrenergic receptor in apo state |
Heteromer P07550; P63098; P63328; | 100 | 1×FK5; | |||
| cryo-EM structure of calcineurin-fused beta2 adrenergic receptor in carazolol bound inactive state |
Heteromer P07550; P63098; P63328; | 100 | 1×CAU; 1×FK5; | |||
| Structure of SlyD delta-IF from Thermus thermophilus in complex with S2-W23A peptide |
Heteromer P0A7V0; Q5SLE7; | 100.0 | 1×CL; 4×CA; 1×NI; | |||
| Structure of SlyD delta-IF from Thermus thermophilus in complex with S3 peptide |
Heteromer P0A7V3; Q5SLE7; | 100.0 | 1×CL; 4×CA; 1×NI; | |||
| Isomerase Protein | homo-2-mer | 100 | 2×SO4; | |||
| FK506 BINDING PROTEIN FKBP MUTANT R42K/H87V COMPLEX WITH IMMUNOSUPPRESSANT FK506 | homo-2-mer | 98.13 | 2×FK5; | |||
| ATOMIC STRUCTURE OF FKBP-FK506, AN IMMUNOPHILIN-IMMUNOSUPPRESSANT COMPLEX | homo-2-mer | 100 | 2×FK5; | |||
| ATOMIC STRUCTURE OF FKBP12-FK506, AN IMMUNOPHILIN IMMUNOSUPPRESSANT COMPLEX | homo-2-mer | 100 | 2×FK5; | |||
| FK-506 BINDING PROTEIN: THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX WITH THE ANTAGONIST L-685,818 | homo-2-mer | 100 | 2×818; | |||
| FK-506-BINDING PROTEIN: THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX WITH THE ANTAGONIST L-685,818 | homo-2-mer | 100 | 2×FK5; | |||
| FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND | homo-2-mer | 99.06 | 2×AP1; | |||
| FK506 BINDING PROTEIN MUTANT, HOMODIMERIC COMPLEX | homo-2-mer | 99.06 | ||||
| FKBP12-FK1012 COMPLEX | homo-2-mer | 100 | 1×FKA; | |||
| DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRU… | homo-2-mer | 100 | 2×SB1; | |||
| FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-709,858 | homo-2-mer | 100 | 2×858; 1×B7G; | |||
| FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-707,587 | homo-2-mer | 100 | 2×587; | |||
| Crystal structure of FRB-FKBP fusion protein in complex with rapamycin | monomer | 100 | 1×RAP; | |||
| Lysine dimethylated FKBP12 | monomer | 100 | ||||
| Crystal structure of FKBP12 | monomer | 100 | ||||
| Crystal structure of E60Q mutant of FKBP12 | monomer | 99.06 | ||||
| FKBP12 in complex with the BMP potentiator compound 10 at 1.00A resolution | monomer | 100 | 1×OOZ; 1×CD; 2×CL; 1×NA; | |||
| FKBP12 in complex with the BMP potentiator compound 6 at 1.03A resolution | monomer | 100 | 1×OP5; 1×CD; 2×CL; 1×NA; | |||
| Human FKBP12 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfinyl)-3-(pyridin-2-ylmethyl… | monomer | 99.06 | 1×UT6; 1×DMS; 2×CD; 6×CL; 1×SO4; | |||
| FKBP12 in complex with the BMP potentiator compound 8 at 1.12A resolution | monomer | 100 | 1×OP8; | |||
| Structural basis of conformational transitions in the active site and 80 s loop in the FK506 bindin… | monomer | 98.13 | 1×SO4; | |||
| FKBP12 in complex with PROTAC 6a2 | monomer | 99.06 | 1×Y5Q; | |||
| Crystal structure of E60A mutant of FKBP12 | monomer | 99.06 | ||||
| FKBP12 mutant V55G bound to Rapa*-3Z | monomer | 99.06 | 1×LWR; 1×GOL; | |||
| Human FKBP12 in complex with (1S,5S,6R)-9-((3,5-dichlorophenyl)sulfonyl)-3-(pyridin-2-ylmethyl)-5-v… | monomer | 99.06 | 1×USV; 1×DMS; 3×GOL; 4×CD; 2×SO4; | |||
| FKBP12 in complex with the BMP potentiator compound 9 at 1.55 A resolution | monomer | 100 | 1×818; 1×SO4; | |||
| Human FKBP12 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(pyridin-2-ylm… | monomer | 99.06 | 1×UUI; | |||
| Homo sapiens FKBP12 protein bound with APX879 in P32 space group | monomer | 100 | 2×ACT; 1×R27; | |||
| Human FKBP12 in complex with (1S,5S,6R)-10-((R)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(pyridin-2-ylm… | monomer | 99.06 | 1×UQI; 1×DMS; | |||
| Human FKBP12 in complex with (1S,5S,6R)-10-((S)-3,5-dichloro-N-methylphenylsulfonimidoyl)-3-(pyridi… | monomer | 99.06 | 1×UMR; | |||
| Wildtype FK506-binding protein complexed with Rapamycin | monomer | 100 | 1×RAP; 1×GOL; | |||
| FK506-binding protein mutant WF59 complexed with Rapamycin | monomer | 99.06 | 1×RAP; 1×GOL; | |||
| FK506-binding protein mutant WL59 complexed with Rapamycin | monomer | 99.06 | 1×RAP; 1×GOL; | |||
| ATOMIC STRUCTURE OF THE RAPAMYCIN HUMAN IMMUNOPHILIN FKBP-12 COMPLEX | monomer | 100 | 1×RAP; | |||
| Analyzing the visible conformational substates of the FK506 binding protein FKBP12 | monomer | 98.13 | 2×MPD; | |||
| crystal structure analysis of the FKBP12 complexed with 000107 small molecule | monomer | 100 | 1×SUB; | |||
| FK506 BINDING PROTEIN COMPLEXED WITH FKB-001 | monomer | 100 | 1×001; 1×GOL; | |||
| crystal structure analysis of the FKBP12 complexed with 000308 small molecule | monomer | 100 | 1×TST; | |||
| NATIVE FKBP | monomer | 100 | 1×NH4; 1×SO4; | |||
| FKBP COMPLEXED WITH 4-HYDROXY-2-BUTANONE | monomer | 100 | 1×NH4; 1×SO4; 1×BUQ; | |||
| FKBP COMPLEXED WITH DMSO | monomer | 100 | 1×NH4; 1×SO4; 1×DMS; | |||
| FKBP COMPLEXED WITH METHYL METHYLSULFINYLMETHYL SULFIDE (DSS) | monomer | 100 | 1×NH4; 1×SO4; 1×DSS; | |||
| DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRU… | monomer | 100 | 1×SBX; | |||
| DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRU… | monomer | 100 | 1×SB3; | |||
| X-ray Crystal Structure of 28-O-Methylrapamycin complexed with FKBP12: Is the Cyclohexyl Moiety Par… | monomer | 100 | 1×MR8; | |||
| SOLUTION STRUCTURE OF FKBP, A ROTAMASE ENZYME AND RECEPTOR FOR FK506 AND RAPAMYCIN | monomer | 100 | ||||
| SOLUTION STRUCTURE OF FKBP12 COMPLEXED WITH GPI-1046, A NEUROTROPHIC LIGAND | monomer | 100 | 1×GPI; | |||
| SOLUTION STRUCTURE OF FKBP, A ROTAMASE ENZYME AND RECEPTOR FOR FK506 AND RAPAMYCIN | monomer | 100 | ||||
| SOLUTION STRUCTURE OF FKBP, A ROTAMASE ENZYME AND RECEPTOR FOR FK506 AND RAPAMYCIN | monomer | 100 | ||||
| Crystal structure of Fkbp12-IF(SlpA), a chimeric protein of human Fkbp12 and the insert in flap dom… | monomer | 98.8 | ||||
| Crystal structure of Fkbp12-IF(SlyD), a chimeric protein of human Fkbp12 and the insert in flap dom… | monomer | 98.8 | ||||
| Structure of SlyD delta-IF from Thermus thermophilus in complex with FK506 | monomer | 100 | 1×FK5; 2×ZN; 1×CL; 4×GOL; 2×ACT; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8x6p.1.B | monomer | 0.85 | 100.00 | |||